Because there were no enough patients in other counties at that time when China started clinical trial of Remdesivir. The first COVID-19 patient who received Remdesivir was the Seattle patient. China started clinical trial soon after the study of Seattle patient was published.
Because there were no enough patients in other counties at that time when China started clinical trial of Remdesivir. The first COVID-19 patient who received Remdesivir was the Seattle patient. China started clinical trial soon after the study of Seattle patient was published.
把你搞糊涂,有些人的目的就达到了
法匹拉韦意义不大,效果应该远不如瑞德西韦,而且据说会诱导病毒变异。
以前总奇怪为啥国内为啥国内总是做临床研究,不做临床试验
拷了个知乎关于这两词的区别,体会一下
在美国,临床试验是严格定义严格遵守fda规定的活动,结果无论好坏都需要公布并且各种指标都有规定。临床研究属于个人或单位活动,只要给钱的地方同意,结果随便怎么样都无所谓,想发表就发表,想胡编就胡编。
学习了,谢谢。
没有必要为五毛补习。
让他们继续出丑。
正常人的争论或辩论都是基于共同认定的事实,有些人的目的却是把基本的事实搅浑了说
你提醒得对,振聋发聩,看来MRNA可能被垬蓝金黄了,极有可能科研成果已经被厉害国窃取, 有人会抢注专利,立刻提醒FBI!
不知道美国医生在搞什么,完全不拿人命当回事儿,反正病人死了,医生没有按程序出错,医生就不会有问题。
Because there were no enough patients in other counties at that time when China started clinical trial of Remdesivir. The first COVID-19 patient who received Remdesivir was the Seattle patient. China started clinical trial soon after the study of Seattle patient was published.
这逻辑也是真是
看把五毛蠢得,我明明是提醒疫苗公司吸取gild的教训,我都明说了可惜翻墙五毛看不懂